Home

Exploring Early Stages of Alzheimer’s Disease

Meet the Patient CME

Thursday, May 9, 2024 | 11:30 am - 12:00 pm ET

Supported by an independent educational grant from Lilly

overview

What are the early signs and symptoms of Alzheimer’s disease? When should we be concerned? And why are early recognition and diagnosis so important? This webinar, the first of three, will explore the impact of early AD on quality of life and activities of daily living and the importance of early and timely recognition.

faculty

Soo Borson, MD

Professor of Clinical Family Medicine

Keck USC School of Medicine

Los Angeles, California

Professor Emerita of Geriatric Psychiatry

University of Washington School of Medicine

Seattle, Washington

GOAL STATEMENT

The goal of this activity is for learners to be better able to identify the similarities and differences between early stages of Alzheimer’s disease.

TARGET AUDIENCE

This activity is intended for neurologists, primary care physicians, geriatricians, nurse practitioners, and physician assistants.

LEARNING OBJECTIVES

Upon completion of this activity, participants will be better able to:

Identify the differences between mild cognitive impairment and mild AD dementia
Summarize clinical data on the impact of early-stage AD on patient quality of life

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.